Literature DB >> 2712548

Sucralfate reduces the gastrointestinal absorption of norfloxacin.

S H Parpia1, D E Nix, L G Hejmanowski, H R Goldstein, J H Wilton, J J Schentag.   

Abstract

The effect of sucralfate on the bioavailability of norfloxacin after single 400-mg doses of norfloxacin was evaluated in eight healthy males. Subjects received each of the following treatments in random sequence: (i), norfloxacin, 400 mg alone; (ii) sucralfate, 1 g, concurrently with norfloxacin, 400 mg; and (iii) sucralfate, 1 g, followed by norfloxacin, 400 mg, 2 h later. One day before administration of treatments 2 and 3, 1 g of sucralfate was given at 7 a.m., 11 a.m., 5 p.m., and 10 p.m. Blood samples were collected immediately before the norfloxacin dose and at 0.25, 0.5, 0.75, 1.0, 1.5, 2, 3, 4, 6, 8, 12, and 24 h postdose. Urine was collected in divided intervals: from 0 to 12, from 12 to 24, and from 24 to 48 h. Norfloxacin concentrations in plasma and urine were determined by high-performance liquid chromatography. Mean area under the plasma concentration-versus-time curve extrapolated to infinity decreased significantly (P less than 0.001) after norfloxacin was given with and 2 h after sucralfate. The relative bioavailabilities were 1.8% when norfloxacin was taken with sucralfate and 56.6% when it was taken 2 h after sucralfate. After norfloxacin was given alone, the mean norfloxacin concentrations in urine collected during intervals of 0 to 12, 12 to 24, and 24 to 28 h were 118.9 +/- 72.3, 18.8 +/- 12.5, and 2.4 +/- 2.2 micrograms/ml, respectively. After norfloxacin was given with sucralfate, however, the mean norfloxacin concentrations in urine collected during the same time intervals were 6.8 +/- 4.7, 1.8 +/- 1.4, and 0 +/- 0 microgram/ml, respectively. Because of low pH and relatively high magnesium concentration in urine, susceptibilities of bacteria in urine are 8- to 32-fold lower than in broth. This fact, in combination with the reduced bioavailability of norfloxacin in the presence of sucralfate or antacids, is likely to result in treatment failure. The effect of sucralfate given after norfloxacin was not examined, nor was the effect of sucralfate given more than 2 h before norfloxacin. Administration or norfloxacin with sucralfate should therefore by avoided.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712548      PMCID: PMC171428          DOI: 10.1128/AAC.33.1.99

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.

Authors:  H J Zeiler
Journal:  Drugs Exp Clin Res       Date:  1985

2.  Lack of effect of sucralfate on prednisone bioavailability.

Authors:  J G Gambertoglio; D R Romac; C L Yong; J Birnbaum; P Lizak; W J Amend
Journal:  Am J Gastroenterol       Date:  1987-01       Impact factor: 10.864

3.  Effect of sucralfate on ibuprofen absorption in normal volunteers.

Authors:  M C Pugh; R E Small; W R Garnett; R J Townsend; H E Willis
Journal:  Clin Pharm       Date:  1984 Nov-Dec

4.  Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH.

Authors:  R Nagashima; N Yoshida
Journal:  Arzneimittelforschung       Date:  1979

Review 5.  Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.

Authors:  D E Nix; J M DeVito
Journal:  Clin Pharm       Date:  1987-02

6.  Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.

Authors:  G P Gesu; C Eftimiadi; E Debbia; G C Schito
Journal:  Drugs Exp Clin Res       Date:  1987

7.  Norfloxacin disposition after sequentially increasing oral doses.

Authors:  B N Swanson; V K Boppana; P H Vlasses; H H Rotmensch; R K Ferguson
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

8.  Cimetidine absorption in humans during sucralfate coadministration.

Authors:  R D'Angio; M Mayersohn; K A Conrad; M Bliss
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

9.  Evaluation of a potential drug interaction between sucralfate and aspirin.

Authors:  A H Lau; C W Chang; P K Schlesinger
Journal:  Clin Pharmacol Ther       Date:  1986-02       Impact factor: 6.875

10.  Selective binding of sucralfate to gastric ulcer in man.

Authors:  S Nakazawa; R Nagashima; I M Samloff
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

View more
  33 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.

Authors:  H Stass; M F Böttcher; K Ochmann
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.

Authors:  J A Zix; H F Geerdes-Fenge; M Rau; J Vöckler; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.

Authors:  W A Krueger; G Ruckdeschel; K Unertl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

5.  Effects of two cations on gastrointestinal absorption of ofloxacin.

Authors:  M Martínez Cabarga; A Sánchez Navarro; C I Colino Gandarillas; A Domínguez-Gil
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Effect of staggered dose of calcium on the bioavailability of ciprofloxacin.

Authors:  B M Lomaestro; G R Bailie
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

7.  Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.

Authors:  K M Deppermann; H Lode; G Höffken; G Tschink; C Kalz; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 8.  Fluoroquinolones: interaction profile during enteral absorption.

Authors:  K M Deppermann; H Lode
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 9.  Drug interactions with quinolone antibacterials.

Authors:  J R Brouwers
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

Review 10.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.